Evaluation of treatment efficacy after switching to dolutegravir-lamivudine dual therapy in people living with HIV

Ergen P., Bektas B., Aydin O., Keskin H., uecisik A. C., Karadag F. Y., ...Daha Fazla

AFRICAN HEALTH SCIENCES, cilt.22, sa.3, ss.426-435, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22 Sayı: 3
  • Basım Tarihi: 2022
  • Doi Numarası: 10.4314/ahs.v22i3.46
  • Dergi Adı: AFRICAN HEALTH SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, Index Islamicus, MEDLINE, Pollution Abstracts, Veterinary Science Database
  • Sayfa Sayıları: ss.426-435
  • Anahtar Kelimeler: dolutegravir, lamivudine, dual, antiretroviral therapy, efficacy, PLUS RALTEGRAVIR, SPARING REGIMEN, TENOFOVIR, PROTEASE, RISK, TOLERABILITY, INHIBITORS, EXPOSURE, DENSITY, SAFETY
  • Ankara Üniversitesi Adresli: Evet

Özet

Background: People living with HIV need to use antiretroviral therapy throughout their lives.